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Abstract
Background
We searched for indicators to predict the prognosis of infectious peritonitis by measuring
levels of complement proteins and activation products in peritoneal dialysis (PD) fluid (PDF)
of patients at early stages of peritonitis. We retrospectively analyzed the relationship
between the levels of sC5b-9, C3 and C4 in PDF and the subsequent clinical prognosis.
Methods
We measured levels of sC5b-9, C3 and C4 in PDF on days 1, 2 and 5 post-onset of peritonitis
in 104 episodes of infectious peritonitis in PD patients from 2008 and retrospectively com-
pared levels with clinical outcomes. Further analysis for the presence of causative microor-
ganisms or to demonstrate bacterial culture negative peritonitis was performed and correlated
with change of levels of sC5b-9 in PDF.
Results
When PD patients with peritonitis were divided into groups that either failed to recover from
peritonitis and were finally withdrawn from PD (group 1; n = 25) or recovered (group 2; n =
79), levels of sC5b-9, C3 and C4 in PDF were significantly higher in group 1 patients com-
pared to those in group 2 on day5. Analysis of microorganisms showed significantly higher
sC5b-9 levels in PDF of peritonitis cases caused by culture negative peritonitis in group 1
compared with group 2 when we analyzed for individual microorganisms. Of note, on day5,
the sC5b-9 levels in PDF were similarly high in peritonitis caused by fungi or other organisms.
Conclusion
Our results suggested that levels of complement markers in PDF, especially sC5b-9, have
potential as surrogate markers to predict prognosis of PD-related peritonitis.
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Introduction
Infectious peritonitis is an important complication that prevents long term peritoneal dialysis
(PD) therapy in end-stage renal disease patients [1,2]. For peritonitis that does not respond
to any antibiotic therapies, removal of the PD catheter is required. The International Society
of Peritoneal Dialysis 2010 guideline recommends that the PD catheter is removed when peri-
tonitis is not improved by 5 days after onset [3]. It is then usually necessary to transfer to
hemodialysis (HD) in these patients; this requires surgical operations both to remove the PD
catheter and to make the arteriovenous fistula for HD therapy. These events are very stressful
for patients, leading clinicians to delay performance of these procedures if the patient does not
have obvious symptoms of peritonitis. Markers of likely outcome would aid clinical decision-
making and improve patient outcome.
The complement (C) activation system is an important defense system to protect the host
from attack by invasive microorganisms. In contrast, excessive C activation can drive inflam-
mation and damage host cells and tissues [4,5]. Therefore, it is important to maintain the bal-
ance between C activation and suppression. Tight regulation of the C system is required to
maintain homeostasis and to prevent tissue injures in the host [4,5]. As we previously reported,
membrane C regulators (CRegs) play key roles to maintain host homeostasis in the healthy
peritoneum [6]. When inflammation was induced in the peritoneum in the rat model, inhibi-
tion of CRegs resulted in uncontrolled local C activation and enhanced peritoneal injuries
[7,8]. Although C activation protects the host from invasion of microorganisms in peritoneum,
unregulated activation of the C system destroys the peritoneum. In PD fluids (PDF) from
patients, C proteins such as C3 and C4 were observed [9] and local production was shown
from human peritoneal mesothelium under PD [10] suggesting capacity for control of inflam-
mation/infection in peritoneum. We also reported that the CRegs CD46, CD55 and CD59
are broadly distributed in human peritoneum [11], suggesting that the balance of C activation
and regulation might be important to maintain homeostasis in human peritoneal cavity.
When PD-related peritonitis occurs, activation and/or dysregulation of the C system could be
induced in the peritoneum. In this context, it is relevant to clarify detail of components and
products of C activation in PD fluid during individual episodes of peritonitis in PD patients
and the relationship between prognosis of peritonitis and generated C products. Therefore, we
searched for indicators to predict the prognosis of infectious peritonitis by measuring levels of
C components and activation products in PDF of PD patients at early stage of peritonitis, espe-
cially culture negative peritonitis.
Materials and Methods
PDF samples of PD patients
PDFs with overnight dwell were collected from 104 peritonitis cases on days 1, 2 and 5 post-
onset from May 2008 to December 2013 in Nagoya University Hospital and Daiyukai Daiichi
Hospital and Jan 2012 to December 2012 in Handa City Hospital. S1 Table shows number of
PD patients, total number of peritonitis episodes and number of sample episodes in each insti-
tute during the periods. The present study was approved by the Ethics Committee for Human
Research of the Faculty of Medicine at Nagaya University (Approval numbers 298, 309 and
2013–2075), subsequently by the ethical committees of Daiyukai-daiichi Hospital and Handa
City Hospital. We used samples of patients who had provided their written agreements in the
hospital to the use of their PDF and demographic/laboratory data in the present study. The
ethical committees approves the above procedure. The basic patient profiles of each institute
are shown in S1 Table. The collected PDF samples were centrifuged promptly and the
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supernatants were kept at -80˚C until measurement of C proteins by enzyme-linked immuno-
sorbent assays (ELISA).
We retrospectively collected data of total white blood cell count in PDF, serum levels of C-
reactive protein, C3, C4 and CH50, and results of bacterial cultures of PDF from medical rec-
ords. Peritonitis was diagnosed according to the 2010 guideline of the International Society for
Peritoneal Dialysis (ISPD) [3]. We also collected laboratory data of levels of serum albumin (g/
dL) and creatinine (mg/dL), blood urea nitrogen and hemoglobin (g/dL) within one month
before each episode of peritonitis from the medical records.
To analyze prognosis, we divided the 104 peritonitis cases into two groups as follows; with-
drawal from PD therapy caused by peritonitis (group1; n = 25); finally recovered from perito-
nitis (group2; n = 79).
Methods of bacterial cultures from PD effluent
For bacterial cultures to identify the causative microorganisms, a combination of the following
two methods, recommended in the 2010 ISPD guideline [3], were performed in Nagoya Uni-
versity Hospital and Handa City Hospital throughout the observational periods and in Daiyu-
kai-daiichi Hospital from April 2011. In the first method, 50 mL PD effluent was centrifuged,
the sediment was directly inoculated for culture on standard culture media. In the second
method, 10mL of PD effluent was inoculated into standard blood-culture media under aerobic
or anaerobic condition. Regarding patients presenting at the emergency room on bank holi-
days or at night, bacterial culture was limited to the second method only because of logistic
issues. PD patients with peritonitis presenting in Daiyukai-daiichi Hospital were also only
tested using the second method until March 2011.
Measurements of levels of total protein, soluble C5b-9 (sC5b-9), C3 and
C4 in PD fluids
To measure levels of sC5b-9, C3 and C4 in PDF, we used the MicroVueTM sC5b-9 Plus EIA kit
(Quidel Co., San Diego, CA), AssayMax Human Complement C3 ELISA kit and AssayMax
Human Complement C4 ELISA kit (Assaypro LLC, St. Charles, MO), respectively. These mea-
surements were performed according to the manufacturer’s instructions. Total protein
amounts in PDF were also measured by BCA protein assay reagent (Thermo Fisher Scientific)
to adjust levels of sC5b-9, C3 and C4 in PDF. Firstly, we simply measured sC5b-9 levels in
PDF and compared the raw data with total protein amounts in PDF and white blood cell
(WBC) counts in PDF. Secondly, each complement analyte level was adjusted by the total pro-
tein level of PDF as in the example below;
Adjusted sC5b-9 level in PDF (ng/mg) = (sC5b-9 level in PDF (ng/mL)) / (protein level in
PDF (mg/mL)
Adjusted C3 or C4 level in PDF (μg/mg) = (C3 or C4 level in PDF (μg/mL)) / (protein level
in PDF (mg/mL)
Percent change of sC5b-9 levels in PDF was also calculated as below;
sC5b-9 (D2-D1)/D1 (%) = {(adjusted sC5b-9 level in PDF on day 2)–(adjusted sC5b-9 level
in PDF on day1)} / (adjusted sC5b-9 level in PDF on day1) × 100
sC5b-9 (D5-D1)/D1 (%) = {(adjusted sC5b-9 level in PDF on day 5)–(adjusted sC5b-9 level
in PDF on day1)} / (adjusted sC5b-9 level in PDF on day1) × 100
sC5b-9 (D5-D2)/D2 (%) = {(adjusted sC5b-9 level in PDF on day 5)–(adjusted sC5b-9 level
in PDF on day2)} / (adjusted sC5b-9 level in PDF on day2) × 100
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Relationship between and time course of adjusted sC5b-9 and WBC
counts in PDF
We compared adjusted sC5b-9 levels in PDF and WBC counts in PDF between groups 1 and 2
on days 1, 2 and 5. We further performed multivariate logistic regression analysis to statisti-
cally evaluate the predictive ability of those biomarkers on day 5 for subsequent clinical
outcomes.
Statistical analysis
Data was summarized as median (interquartile range) for continuous variables and number
(%) for categorical variables. Baseline data was compared between group 1 and group 2 with
Mann-Whitney U test or Fisher’s exact test as appropriate.
Spearman’s rank correlation coefficients were calculated to examine correlation between
adjusted sC5b-9 levels in PDF with counts of WBC in PDF.
Intergroup comparison was performed using Kruskal-Wallis test, followed by Mann-Whit-
ney U test for post-hoc pairwise comparisons. Intragroup comparison was performed using
Friedman test, followed by Wilcoxon signed-rank test for pairwise comparison with day 1. To
address the multiplicity of comparison, Bonferroni method was applied to calculate corrected
P-values.
Using multivariate logistic regression models, we examined whether the prediction capabil-
ity of group 1 is improved by the addition of sC5b-9, C3, or C4 at day 5 to the model consisting
of a conventional predictive factor, WBC (Model 1). Baseline imbalance in patient’s character-
istics was adjusted in the models. We evaluated the improvement of the prediction capability
by calculating concordance index (c-index), net reclassification improvement (NRI), and inte-
grated discrimination improvement (IDI). To predict withdrawal from PD because of perito-
nitis, threshold value of adjusted sC5b-9 level in PDF was calculated by receiver operating
characteristics analysis to estimate optimal cut-off value.
A two-sided P-value of<0.05 was considered significant. Statistical analyses were carried
out using IBM SPSS Statistics 23.0 (International Business Machines Corp, Armonk, NY) and
R version 3.2.2 (R Foundation for Statistical Computing, Vienna, Austria).
Results
Comparison of background and basic data
Comparison of the background patient characteristics between Groups 1 and 2, age, gender,
and status of diabetes mellitus as a background disease, revealed no significant differences.
Duration of PD therapy prior to the episode of peritonitis was slightly but significantly longer
in group 1 than in group 2.
Serum creatinine levels and blood urea nitrogen level measured within one month before
the episode of peritonitis were not significantly different between groups 1 and 2. Serum albu-
min levels in group 1 tended to be lower compared with group 2. No significant differences in
serum levels of C3, C4, CH50, and WBC counts in PDF, were observed between groups 1 and
2. These background data are summarized in Table 1.
In the 104 peritonitis episodes, causative microorganisms that could be evaluated are listed
in Table 2; 33.7% of the cases were culture negative under bacterial examination. The majority
of culture-positive infections were with gram positive microorganisms but there were multiple
species observed. The distribution of microorganism species was similar to that recorded in
our local PD registry [1].
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Levels of sC5b-9 and protein in PDF from PD patients with peritonitis
Levels of sC5b-9 in PDF were significantly correlated with those of protein and WBC counts
in PDF on day 1, 2, and 5 (data not shown). When we compared sC5b-9 levels, protein levels
and WBC counts in PDF among four categories based on causative microorganisms (gram
positives, gram negatives, fungus, culture negative), significant differences among four cat-
egories were observed on day 5 but not on day 1 (Fig 1). Leakage of protein into PDF was
Table 1. Comparison of Background of patients.
Group 1 Group 2 P-valuea
Number of peritonitis episodes 25 79
Age (years) 67 (58, 75) 67 (60, 73) 0.684
Male/Female 22 (88.0)/3 (12.0) 59 (74.7)/20 (25.3) 0.268
DM/non DM 11 (44.0)/14 (56.0) 39 (49.4)/40 (50.6) 0.655
PD history (month) 46 (21, 69) 24 (10, 45) 0.013*
Serum albumin level (g/dL) 2.9 (2.5, 3.4) 3.3 (2.9, 3.6) 0.067
Blood urea nitrogen level (mg/dL) 52.1 (40.0, 62.7) 48.0 (39.0, 59.0) 0.396
Serum creatinine level (mg/dL) 8.40 (7.00, 10.41) 8.08 (7.05, 9.86) 0.670
Serum C3 level (mg/dL) 86 (84, 102) 94 (84, 111) 0.225
Serum C4 level (mg/dL) 27 (24, 33) 30 (27, 34) 0.272
Serum CH50 (U) 43.5 (37.6, 52.0) 42.7 (39.6, 50.8) 0.650
Notes: Data are shown as median (interquartile range) or number (%). Raw data is shown in S2 Table.
aMann-Whitney U test for continuous data, Fisher’s exact test for categorical data.
*P<0.05
doi:10.1371/journal.pone.0169111.t001
Table 2. List of causative organisms in peritonitis.
n (%) Microorganisms Group 1 Group 2
Gram positives 6 (24.0) 37 (46.8)
Streptococcus sp. 0 (0) 13 (16.5)
Staphylococcus aureus 2 (8.0) 5 (6.3)
coagulase-negative staphylococcus (CNS) 3 (12.0) 11 (13.9)
Enterococcus sp. 1 (4.0) 6 (7.6)
Micrococcus sp. 0 (0) 1 (1.3)
Un-classified 0 (0) 1 (1.3)
Gram negatives 10 (40.0) 11 (13.9)
Escherichia coli 2 (8.0) 2 (2.5)
Pseudomonas aeruginosa 3 (12.0) 0 (0)
Acinetobacter sp. 0 (0) 6 (7.6)
Chryseobacterium sp. 1 (4.0) 1 (1.3)
• Serratia sp. or Others 4 (16.0) 2 (2.5)
• (Pseudomonas sp.,
• Klebsiella sp.,
• Bacteroides sp.,
• Alcaligenese sp.,
• un-classified)
Fungus 5 (20.0) 0 (0)
Candida sp. 4 (16.0) 0 (0)
Cryptococcus sp. 1 (4.0) 0 (0)
Culture negatives 4 (16.0) 31 (39.2)
Total 25 (100) 79 (100)
doi:10.1371/journal.pone.0169111.t002
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significantly correlated with sC5b-9 levels in PDF. As previously reported [12,13], in non-
inflamed peritoneum without peritonitis, leakage of proteins larger than α2-macroglobulin
was minimal from blood to peritoneal cavity. The sC5b-9 complex has a molecular mass in
excess of 106 Da, more than that of α2-macroglobulin (750kDa), and is unlikely to significantly
traverse the selective barrier of peritoneum, suggesting that measured sC5b-9 in PDF was
mainly locally produced. However, components of sC5b-9 in PDF might be considered to leak
from blood dependent on the level of total protein, because total protein level in PDF was well
correlated with levels of sC5b-9 in PDF. This point may be supportive to follow corrected levels
of sC5b-9 even if the uncorrected values might have the same predictive capability for out-
come. Therefore, we adjusted sC5b-9 levels in PDF with protein levels in the PDF for the fur-
ther analyses.
Protein-adjusted levels of sC5b-9, C3 and C4 and counts of WBC in
PDFs from PD patients with peritonitis
Statistically significant differences of adjusted sC5b-9 levels, adjusted C3 levels, adjusted C4
levels and counts of WBC in PDF were observed between days 1, 2 and 5 in group 2 (p<0.001)
but not in group 1. Compared with day 1, significant decreases in adjusted sC5b-9, C3 and C4
levels in PDF were observed on day 5 (p<0.001), and also in counts of WBC levels in PDF on
days 2 and 5 (p<0.01 and p<0.001, respectively). There were no significant differences
between group 1 and group 2 in levels of all complement markers in PDF on days 1 and 2 (Fig
2), whereas all of them were significantly lower in group 2 than in group 1 on day 5. WBC
counts in PDF were also lower in group 2 than in group 1 on day 5. Because levels of adjusted
sC5b-9, C3 and C4 in PDF were different between groups 1 and 2 on day 5, we further ana-
lyzed these markers focusing on day 5.
Percent changes of adjusted sC5b-9, C3 and C4 in PDFs from PD
patients with peritonitis
Percentage changes of adjusted sC5b-9, C3 and C4 levels in PDF were not significantly differ-
ent between groups 1 and 2 from day 1 to day 2, whereas they were significantly larger in
group 1 from day 2 to day 5 and from day 1 to day 5 (Fig 3A, 3B and 3C).
Levels of adjusted sC5b-9, C3 and C4 in PDF on day 5 for four
categories of microorganisms causing peritonitis
When bacteriological results were categorized into gram positive, gram negative, fungus or
culture negative, adjusted levels of sC5b-9 in gram positive and culture negative PDF were sig-
nificantly higher in group 1 than in group 2 (Fig 4A). No significant difference was observed
in adjusted C3 levels between groups 1 and 2 (Fig 4B), while adjusted levels of C4 in gram neg-
ative infected PDF were significantly higher in group 1 compared to group 2 (Fig 4C). All
cases with fungal peritonitis were withdrawn from PD according to recommendation of the
ISPD guideline immediately after fungal infection was identified, therefore we could not statis-
tically compare fungal peritonitis between groups 1 and 2. However, adjusted levels of sC5b-9,
Fig 1. Measurements of sC5b-9, total protein and WBC in PDFs on peritonitis days 1 and 5. All cases were categorized into gram positives,
gram negatives, fungal infection (fungus) and culture negative based on identified causative microorganisms. (A) and (B) show levels of sC5b-9 in
peritoneal dialysates (PDFs); (C) and (D) show levels of total protein in PDF; (E) and (F) show white blood cells (WBC) counts in PDF. (A), (C) and
(E), day 1 post-onset; (B), (D) and (F), day 5 post-onset. Statistical tests with Kruskal-Wallis test followed by Mann-Whitney U test and Bonferroni
correction. *, p<0.05; **, p<0.01.
doi:10.1371/journal.pone.0169111.g001
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C3 and C4 were similarly high in fungal infected PDF in group 1as the other three categories
in group 1.
Levels of adjusted sC5b-9, C3 and C4 in PDF on Day 5 stratified by
individual species of microorganisms causing peritonitis
Culture positive peritonitis cases were categorized into coagulase-negative staphylococci (CNS),
Staphylococcus aureus, Streptococcus, Enterococcus, other gram positives, Pseudomonas aerugi-
nosa, E.coli, Acinetobacter, other gram negatives, or fungus and analyzed in the same way
(Fig 5A); on day 5 adjusted sC5b-9 levels in culture negative PDF were significantly higher in
withdrawal PD patients (group 1) compared with patients who continued on PD (group 2)
(p<0.05). No significant differences between outcome groups 1 and 2 in adjusted PDF levels
of sC5b-9 were found in peritonitis caused by other kinds of microorganisms, with a limitation
of small group sizes in these analyses (Fig 5A). In PDF of group 2 patients infected with
Fig 2. PDF levels of adjusted sC5b-9, C3 and C4 and WBC counts after onset of peritonitis. PDF levels of sC5b-9, C3 and C4 adjusted for total
protein on Days 1, 2 and 5 after onset of peritonitis are shown in (A), (C) and (D), respectively. Counts of WBC in PDFs are shown in (B). Gray hatched bar
is group 1 and open hatched bar is group 2. ns., not significant. Statistical tests with Mann-Whitney U test and Bonferroni correction.
doi:10.1371/journal.pone.0169111.g002
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Staphylococcus aureus, adjusted C3 was high differed from those infected with other microor-
ganisms (Fig 5B). However, no significant differences were observed in adjusted C3 and C4
levels between groups 1 and 2 for individual microorganisms.
Percent changes of sC5b-9 levels in PDF in relation to causative
microorganisms
We focused on percent changes of adjusted PDF levels of sC5b-9 because the largest differ-
ences in a selected analysis between groups 1 and 2 were observed in adjusted sC5b-9 levels in
PDF (Fig 3A). When causative microorganisms were divided into four categories: gram posi-
tive, gram negative, fungal and culture negative peritonitis, percent changes of levels of
adjusted sC5b-9 in PDF between days 1, 2 and 5 of peritonitis varied depending on the catego-
ries of microorganisms (Fig 6). Percent changes in adjusted sC5b-9 levels in PDF from day 2
to day 5 and from day 1 to day 5 were significantly greater in group 1 than in group 2 when
peritonitis was caused by gram positive bacteria or was culture negative (Fig 6A and 6D), but
percent change of adjusted sC5b-9 levels in PDF were not different between the two groups in
gram negative peritonitis (Fig 6B). Of note, percent changes of PDF levels of adjusted sC5b-9
in fungal peritonitis were apparently increased from day 2 to day 5 compared to from day 1 to
day 2 and from day 1 to day 5. This phenomenon was not observed in other three categories in
group 1 (Fig 6C). Regarding Fungus, we could not perform intergroup comparison because
there were no fungal peritonitis cases in group 2.
Usefulness of adjusted sC5b-9 levels and WBC counts in PDF to predict
prognosis on day 5
When we compared levels of adjusted sC5b-9 levels in PDF with counts of WBC in PDF as a
conventional peritonitis marker, a significant correlation was observed on days 1 and 5 (S1
Fig). However, when groups 1 and 2 were analysed individually, significant correlation was
not found on any day in group 1 although significant correlation was still found on days 1 and
5 in group 2.
Focusing on day 5, levels of adjusted sC5b-9, adjusted C3 and adjusted C4 in PDF and
counts of WBC in PDF were significantly higher in groups 1 than in group 2 (Fig 7). Therefore,
a multivariate analysis was performed among these four measurements at this timepoint. Base-
line imbalance was observed in PD history and albumin levels. These two variables were con-
sidered as adjusting factors and included in the logistic regression models (Table 3). In Model
1, WBC was a significant predictor of group 1 (OR per 100 units [95%CI], 1.125 [1.063, 1.194];
P< 0.001), in which c-index was 0.903.
In Model 2, in which sC5b-9 was added to model 1, WBC and sC5b-9 were significant inde-
pendent predictors of group 1. Odds ratios (95% CI; P-value) for WBC (per 100 units) and
sC5b-9 (per 10 units) were 1.080 (1.016, 1.147; P = 0.013) and 1.262 (1.049, 1.518; P = 0.014),
respectively. The c-index in model 2 was 0.918 which increased from that in Model 1. NRI
showed significantly improved classificatory ability compared with Model 1. IDI, though not
significant, showed a trend of improved classificatory ability compared with Model 1 (NRI
[95% CI], 0.74 [0.31, 1.17], P< 0.001; IDI [95% CI], 0.05 [-0.01, 0.12], P = 0.126).
Fig 3. Percent change of the PDF levels of adjusted sC5b-9, C3 and C4 after onset of peritonitis. (A)
shows percent change of adjusted levels in PDF of sC5b-9 (A), C3 (B) and C4 (C). (D2-D1)/D1, (D5-D2)/D2 or
(D5-D1)/D1 shows changes from days 1 to 2, from days 2 and 5, or from day 1 to 5, respectively. Gray filled
hatched bar is group 1 and open hatched bar is group 2. Statistical tests with Mann-Whitney U test and
Bonferroni correction. ns., not significant.
doi:10.1371/journal.pone.0169111.g003
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Meanwhile, in the models wherein C3 or C4 were added to Model 1, these factors were not sta-
tistically significant predictors of group 1, and the prediction capability was not improved either.
In the present study, optimal threshold of adjusted sC5b-9 value in PDF on day 5 to predict
withdrawal, calculated as maximum value of the sum of sensitivity and false positive ratio, was
54.3 (area under the curve: 0.833, 95% CI: 0.730–0.936).
Temporal changes in levels of adjusted sC5b-9 and counts of WBC in individual PD cases
in group 1 fitted one of the following 4 patterns: (A) levels of adjusted sC5b-9 increased, WBC
decreased on day 5; (B) levels of adjusted sC5b-9 decreased or unchanged, WBC increased;
(C) levels of adjusted sC5b-9 and WBC increased; (D) levels of adjusted sC5b-9 and WBC
decreased (S2 Fig). Of note, the pattern (A) was observed in 36% of group 1 cases, suggesting
that the combined use of WBC and levels of sC5b-9 in PDF might help to predict outcomes of
peritonitis in PD patients.
Discussion
In the present study, PD patients with peritonitis were divided into two groups that either
failed to recover from peritonitis and were finally withdrawn from PD (group 1) or recovered
from peritonitis (group 2). Protein-adjusted levels of sC5b-9, C3 and C4 in day 5 PDF of group
1 patients were significantly higher than those in group 2. Because the day 5 differences in lev-
els of sC5b-9 were the largest differences observed between groups 1 and 2, we focused atten-
tion on sC5b-9 levels as a potential biomarker of outcome in PDF. When we assessed levels
of sC5b-9 among four infection categories in PD-related peritonitis on day 5, PDF adjusted
sC5b-9 levels in culture negative peritonitis and in peritonitis caused by gram positive bacteria
were significantly higher in cases that progressed to withdrawal from PD (group 1) compared
to recovery cases (group 2). We compared the changes of adjusted sC5b-9 levels in PDF
between days 1 and 5 or between days 2 and 5 in these groups to ascertain whether changes in
levels were more predictive; however, the results for most cases were similar to simply mea-
suring adjusted sC5b-9 levels in PDF on day 5. We next separately assessed sC5b-9 levels in
PDF from cases grouped by causative microorganism (including culture negatives) to assess
whether this finding was organism-specific; adjusted sC5b-9 levels in PDF from group 1 cases
were significantly increased compared with group 2 in culture negative peritonitis but in other
groups failed to reach significance likely because of sample size limitations. Changes of sC5b-9
levels between days 1 and 5 or between days 2 and 5 were also significantly higher in group 1
compared to group 2 in gram positive and culture negative peritonitis. Sample size prevented
statistical analysis for each species of the microorganisms.
The data show that levels of C proteins and activation products measured in PDF in perito-
nitis may be dependent on the causative microorganisms and sensitivity to the antibodies uti-
lized; and further analyses of C markers might aid identification of the cause of the infection.
Of note, in PDF with peritonitis caused by fungus or Pseudomonas aeruginosa, which had gen-
erally poor prognosis, all cases were withdrawn from PD (group 1), making it impossible to
evaluate relevance of the marker to predict their prognosis; nevertheless, levels of sC5b-9 in
PDF were similarly high in peritonitis caused by these organisms in group 1. Serum levels of
C3, C4 and CH50 were not related to prognosis of peritonitis. We conclude that measurement
Fig 4. PDF levels of adjusted sC5b-9, C3 and C4 on Day 5 for four categories of microorganisms
causing peritonitis. Levels of adjusted sC5b-9, C3 and C4 in PDF were compared for four categories of
microorganisms causing peritonitis on Day 5 after onset of peritonitis. (A) shows levels of adjusted sC5b-9 in
PDF, (B) shows levels of adjusted C3 in PDF, and (C) shows levels of adjusted C4 in PDF. Filled bar is group
1 and open bar is group 2. Statistical tests with Mann-Whitney U test and Bonfferoni correction. ns., not
significant.
doi:10.1371/journal.pone.0169111.g004
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Fig 5. Levels of sC5b-9, C3 and C4 in PDF and relationship to species of microorganism. Levels of sC5b-9, C3 and C4 in PDF from patients with
peritonitis on day 5 after onset of peritonitis and relationship to species of microorganism were investigated. Staphylococcus aureus includes both
methicillin sensitive and methicillin resistant organisms. Gray filled hatched bar is group 1 and open hatched bar is group 2. Statistical tests with Man-
Whitney U test and Bonferroni correction. Culture negative: no growth in bacterial culture examination, CNS: coagulase negative Staphylococcus spp., ns:
not significance.
doi:10.1371/journal.pone.0169111.g005
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of sC5b-9, and perhaps other C activation products in PDF might be helpful to predict progno-
sis of peritonitis in PD patients.
To diagnose PD-related peritonitis and follow the clinical course, WBC in PDF are gener-
ally measured [14,15]. In our study, levels of sC5b-9 in PDF were correlated with WBC counts
in patients with peritonitis. However, levels of adjusted sC5b-9 and WBC in PDF were not cor-
related in patients that failed to recover from peritonitis (group 1). As shown in S2 Fig, various
patterns of temporal change in adjusted sC5b-9 and WBC counts were observed in group 1.
We thus speculated that measurement of sC5b-9 in PDF in addition to WBC counts, might be
of more value than evaluation of only WBC in PDF. Our results of multivariate logistic regres-
sion support this hypothesis, suggesting that the model wherein sC5b-9 was added to WBC
counts improved the predictive ability for withdrawal.
Fig 6. Percent changes of sC5b-9 levels in PDF in relation to causative microorganisms. PDF from cases were divided into four categories: gram
positive bacteria (A), gram negative bacteria (B), fungal infection (C) and culture negative peritonitis (D). Percent changes of sC5b-9 levels were measured
in each category. Gray filled hatched bar is group 1 and open hatched bar is group 2. ns: not significant. Statistical tests with Mann-Whitney U test and
Bonferroni correction.
doi:10.1371/journal.pone.0169111.g006
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Peritonitis remains the biggest challenge to improving prognosis of PD [1,2,16]. The final
decision to withdraw from PD is a difficult one for physicians because of remaining
Fig 7. Levels of adjusted sC5b-9, C3 and C4 and WBC counts in PDF of peritonitis. Levels of adjusted sC5b-9 (A), counts of WBC (B), levels of
adjusted C3 (C) and levels of C4 (D) in PDF are significantly different between groups 1 and 2 on day 5 after incidences of peritonitis. Statistical tests with
Mann-Whitely U test and Bonferroni correction. Each filled circle is from individual case in group 1 and each open circle is from individual case in group2.
doi:10.1371/journal.pone.0169111.g007
Table 3. Logistic regression analysis for withdrawal caused by PD-related peritonitis on day 5.
Model • Predictor
• in PDF
• OR
• 95% CI
• P-value
c-index • NRI
• 95% CI
• P-value
• IDI
• 95% CI
• P-value
Model 1 • WBC
• (per 100)
• 1.125
• 1.060–1.194
• <0.001*
0.903
Model 2 • WBC
• (per 100)
• 1.080
• 1.016–1.147
• 0.013*
0.918 • 0.74
• 0.31–1.17
• <0.001*
• 0.05
• -0.01–0.12
• 0.126
• sC5b-9
• (per 10)
• 1.262
• 1.049–1.518
• 0.014*
Model 3 • WBC
• (per 100)
• 1.126
• 1.054–1.203
• <0.001*
0.904 • 0.00
• -0.42–0.42
• 0.996
• 0.00
• -0.00–0.00
• 0.633
C3 • 0.992
• 0.813–1.210
• 0.938
Model 4 • WBC
• (per 100)
• 1.113
• 1.048–1.182
• 0.001*
0.901 • 0.08
• -0.35–0.51
• 0.719
• 0.00
• -0.01–0.02
• 0.790
C4 • 1.261
• 0.710–2.238
• 0.429
Notes: PDF levels of sC5b-9, C3, and C4 were adjusted for protein levels in PDF. The logistic regression models were adjusted for PD history and serum
albumin levels. PDF, peritoneal dialysis fluid; OR, odds ratio; CI, confidence interval; NRI, net reclassification improvement; IDI, integrated discrimination
improvement; WBC, white blood cells.
*P < 0.05.
doi:10.1371/journal.pone.0169111.t003
Soluble C5b-9 in PD-Related Peritonitis
PLOS ONE | DOI:10.1371/journal.pone.0169111 January 3, 2017 15 / 18
possibilities to control peritonitis by change of antibiotics. The recommendation of the 2010
ISPD guideline is to remove the PD-catheter if peritonitis remains uncontrolled on day 5 post-
onset [3]. However, it is often difficult to know on day 5 whether peritonitis will persist; devel-
opment of new surrogate markers may be helpful for physicians in making the final decision
to remove the PD-catheter on day 5, a decision that precipitates surgical intervention and risk
to the patient. The decision is particularly difficult when PDF bacterial cultures are negative
but clinical peritonitis persists on day 5; both patients and physicians might hesitate to decide
on PD-catheter removal and prefer a wait-and-see strategy that might be dangerous. In future,
improved sensitivity of bacterial identification–for example, by analysis of mRNA fragments
and immunological finger prints [17,18] might help; for the moment, our data suggest that
measurement of levels of sC5b-9 in day 5 PDF may assist in making this difficult decision.
High levels of sC5b-9 predict poor outcome and would support catheter removal while low
levels predict recovery and would give cause for further delay and monitoring.
Our results suggest that levels of C activation products in PDF, especially sC5b-9, might be
biomarkers to aid decision-making regarding treatment of PD patients with peritonitis, espe-
cially culture negative peritonitis. Combinations of sC5b-9, C3 and C4 and other complement
marker levels in PDF might also give clues to the causative bacteria, further improving treat-
ment and outcome. Measuring biomarkers in PDF has advantages because harvesting samples
is easy and not harmful for patients. A limitation of the present study was that the causative
bacterial panel was broad and cases of each microorganism were limited. In our results that
culture negative peritonitis were mostly recovered with conventional antibiotics, culture nega-
tive peritonitis might be many times fastidious coagulase negative staphylococcus as previous
reports described about culture negatives [19–21]. Of course, conventional antibiotics might
be inadequate in some culture negative peritonitis cases of group 1. In future, analyses of the C
system as markers might aid identification of the cause of the infection; it would be helpful to
analyze larger groups of samples to support these results.
Supporting Information
S1 Fig. Correlation between levels of adjusted sC5b-9 and counts of WBC in PDF. (A), (B)
and (C) show correlation between levels of adjusted sC5b-9 and counts of WBC in PDF in
every cases on days 1, 2, and 5, respectively. (D), (E) and (F) show correlation between levels of
adjusted sC5b-9 and counts of WBC in all cases in PDF in group 1 on days 1, 2, and 5, respec-
tively. (G), (H) and (I) show correlation between levels of adjusted sC5b-9 and counts of WBC
in PDF in group 2 on days 1, 2, and 5, respectively. Statistically, correlation between adjusted
sC5b-9 and counts of WBC in PDF was significantly observed on days 1 (A) and 5 (C) when
they were compared in all cases. However, when groups 1 and 2 were analysed individually,
statistical correlation was not found on any day in group 1 (D, E and F) although significant
correlation was still found on days 1 and 5 in group 2 (G and I).
(PDF)
S2 Fig. Combination pattern between levels of adjusted C5b-9 and WBC counts in PDF in
group 1. Each cases in group 1 were observed as four combination pattern between levels of
adjusted sC5b-9 in PDF and counts of WBC in PDF on days 1, 2 and 5 after incidence of peri-
tonitis as the following; levels of adjusted sC5b-9 in PDF increased on day 5 although counts
of WBC decreased in PD (A), levels of adjusted sC5b-9 in PDF decreased or kept the same
level on day 5 although counts of adjusted WBC increased (B), both levels of adjusted sC5b-9
and counts of WBC in PDF increased on day 5 (C), and both levels of adjusted sC5b-9 and
counts of WBC in PDF decreased on day 5 (D).
(PDF)
Soluble C5b-9 in PD-Related Peritonitis
PLOS ONE | DOI:10.1371/journal.pone.0169111 January 3, 2017 16 / 18
S1 Table. Background of the institutes which episodes with peritonitis were studied.
(PDF)
S2 Table. Original data of statistical analysis in the present study.
(PDF)
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